Discover
FirstTake on Pharma - Pharma News and Analysis Podcast
The First Take – Biogen banks on Medicare decision to rescue Aduhelm

The First Take – Biogen banks on Medicare decision to rescue Aduhelm
Update: 2021-10-21
Share
Description
FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the early commercial performance of Biogen’s Aduhelm, a setback in the field of COVID-19 antivirals and a landmark approval for the US biosimilars market.
Comments 
In Channel



